It develops cannabis-based medical products for the treatment of various conditions, including multiple myeloma, psoriasis, post-traumatic stress disorder, chronic pain, and fibromyalgia. OWC Pharmaceutical Research Corp., through its subsidiary, One World Cannabis Ltd., engages in the research and development of cannabis-based medical products. The primary objective of today's weight control program and height-weight standards as outlined in Army Regulation 600-9, - the Army Weight Control Program (AWCP), and AR 40-501 is to ensure all.
